期刊文献+

HIV/AIDS感染者体外诱导的γδT细胞亚群的特点 被引量:3

Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV /AIDS patients in vitro
下载PDF
导出
摘要 目的:了解HIV/AIDS感染者外周血中γδT细胞亚群的特点以及体外诱导后γδT细胞的增殖情况和Vδ1、Vδ2亚群的变化,为γδT细胞体外扩增方法的建立打下基础。方法:流式细胞术(FCM)检测25例HIV/AIDS感染者(HIV组)和31例健康对照者(HC组)外周血中的γδT细胞、Vδ1亚群、Vδ2亚群的频率和绝对值;选择两组中各10例外周血单个核细胞(PBMC),用anti-γδTCR单克隆抗体(mAb)和IL-2在体外诱导培养14 d,在0 d、7 d、14 d分别进行细胞计数和FCM检测,分析比较γδT细胞亚群的比例和培养情况。结果:HIV组外周血中γδT细胞、Vδ2亚群百分比和绝对值都显著低于HC组,而Vδ1亚群百分比和绝对值显著高于HC组;体外诱导培养14 d时,HC组总细胞数量增加3倍,HIV组总细胞数量稍有增加;HC组的γδT细胞比例可达到80%以上,其中Vδ2亚群可以增加到65%左右,而HIV组的γδT细胞比例达35%左右,Vδ2亚群比例仅增加到17%左右。结论:HIV/AIDS感染者外周血中γδT细胞比例显著降低,Vδ1/Vδ2比值倒置;用anti-γδTCR mAb和IL-2在体外诱导HIV/AIDS感染者的Vδ2亚群扩增效果不佳,不能逆转Vδ1/Vδ2倒置现象。应进一步寻找更加有效的诱导培养方法。 AIM: To investigate the characteristics of γδ T cell subsets in peripheral blood and Vδ1 and Vδ2 T cell subsets proliferation after induction in vitro,and to provide experimental basis for γδ T cells expansion methods in vitro.METHODS: Percentages of γδ T cells,Vδ1 and Vδ2 T cells in CD3 T cells from 25 cases of HIV /AIDS patients(HIV group) and 31 cases of healthy adults as control(HC group) were investigated with flow cytometry(FCM);and 10 cases peripheral blood mononuclear cells(PBMCs) from each group were induced and cultured for 14 d by using antiγδ TCR mAb and IL-2,then the cell amounts were counted,γδ T cells and Vδ1,Vδ2 T cells were detected and analyzed with flow cytometry(FCM) at 0 d,7 d and 14 d.RESULTS: The percentages and absolute counts of γδ T cells and V δ2 T cells in HIV group were significantly lower than those in HC group,but those of Vδ1 subsets were significantly higher than those of HC group.After culture for 14 day,the total cell amount of HC group expanded almost 3 times,but those of HIV group expanded a little;The percentages of γδ T cells in HC group were above 80%,but those in HIV group were only about 35%;the percentages of Vδ2 T cells in HC group were about 65%,but those in HIV group were only about 17%.CONCLUSION: The proportion of γδ T cells in peripheral blood of HIV /AIDS patients decreased significantly,and Vδ1 /Vδ2 ratio was inversed;the expansion effect was not so good to use antiγδ TCR mAb and IL-2 to induce γδ T cells and Vδ2 subsets of HIV /AIDS,and the Vδ1 /Vδ2 ratio inversion could not reverse.More efficient culture methods should be explored.
机构地区 解放军
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第3期285-287,290,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(81072423)
关键词 HIV/AIDS ΓΔT细胞 Vδ2亚群 HIV/AIDS γδ T cell Vδ2 subset
  • 相关文献

参考文献11

  • 1张晋渝,石云,邹全明.γδT细胞在感染性疾病中的研究进展[J].细胞与分子免疫学杂志,2011,27(7):825-827. 被引量:7
  • 2Kosub DA,Milush JM,Milush JM,et al.Gamma/Delta T-cell func-tional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections[J].J Virol,2008,82(3):1155-1165.
  • 3Harris LD,Klatt NR,Vinton C,et al.Mechanisms underlying gam-madelta T-cell subset perturbations in SIV-infected Asian rhesus ma-caques[J].Blood,2010,116(20):4148-4157.
  • 4Riedel DJ,Sajadi MM,Armstrong CL,et al.Natural viral suppressors of HIV-1have a unique capacity to maintain gammadelta T cells[J].AIDS,2009,23(15):1955-1964.
  • 5Hebbeler AM,Propp N,Cairo C,et al.Failure to restore the Vgam-ma2-Jgamma1.2repertoire in HIV-infected men receiving highly active antiretroviral therapy(HAART)[J].Clin Immunol,2008,128(3):349-357.
  • 6康宁,崔瑛,周建华,刘庆丰,崔莲仙,巴德年,何维.人外周血γδ T细胞的可溶性anti-TCR γδ抗体扩增及其培养和保存的条件[J].中国肿瘤生物治疗杂志,2009,16(2):106-112. 被引量:2
  • 7Zhang Y,Cao R,Yin F,et al.Lipophilic pyridinium bisphospho-nates:potent gammadelta T cell stimulators[J].Angew Chem Int Ed Engl,2010,49(6):1136-1138.
  • 8Nakajima J,Murakawa T,Fukami T,et al.A phase I study of adop-tive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells[J].Eur J Cardiothorac Surg,2010,37(5):1191-1197.
  • 9Siegers GM,Dhamko H,Wang XH,et al.Human Vdelta1gammad-elta T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells[J].Cyto-therapy,2011,13(6):753-764.
  • 10Sakamoto M,Nakajima J,Murakawa T,et al.Adoptive Immunother-apy for Advanced Non-small CellLung Cancer Using Zoledronate-ex-panded gammadeltaTCells:APhase I Clinical Study[J].J Immu-nother,2011,34(2):202-211.

二级参考文献37

  • 1Hayday AC. [ gamma] [ delta] cells: a right time and a right place for a conserved third way of protection [ J]. Annu Rev Immunol, 2000,18 : 975-1026.
  • 2Chien YH, Konigshofer Y. Antigen recognition by gammadeha T cells [ J]. Immunol Rev, 2007,215: 46-58.
  • 3Viey E, Fromont G, Escudier B, et al. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma [J]. J Immunol, 2005,174(3) : 1338-1347.
  • 4Dieli F, Vermijlen D, Fulfaro F,et al. Targeting human {gamma} deltal T eells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer [ J]. Cancer Res, 2007, 67( 15 ) : 7450-7457.
  • 5Otto M, Barfield RC, Martin WJ, et al. Combination immunotheapy with clinical-scale enriched human gammadelta T cells, hu14. 18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma [ J]. Clin Cancer Res, 2005,11 ( 23 ) : 8486- 8491.
  • 6Yu S, He W, Chen J, et al. Expansion and immunological study of human tumor infiltrating gamnva/deha T lymphocytes in vitro [J]. Int Arch Allergy Immunol, 1999, 119(1 ) : 31-37.
  • 7Zhao J, Huang J, Chen H, et al. Vdeltal T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences [J]. Biochem Biophys Res Commun, 2006, 339( 1 ) : 232 -240.
  • 8Chen H, He X, Wang Z, et al. Identification of human T cell receptor gammadeha-recognized epitopes/proteins via CDR3delta peptide-based immunobiochemical strategy [ J ], J Biol Chem, 2008, 283(18) : 12528-12537.
  • 9Chen J, Niu H, He W, et al, Antltumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes [ J]. Int Arch Allergy Immunol, 2001, 125 (3) : 256-263.
  • 10Wang Z, Zhang T, Hu H, et al. Targeting solid tumors via T cell reeeptor complementarity-determining region 3delta in an engineered antibody [J]. Cancer Lett, 2008, 272(2): 242-252.

共引文献7

同被引文献19

  • 1张宏伟,吴昊.外周血CD4^+CD8^+T细胞研究进展[J].北京医学,2006,28(2):108-110. 被引量:27
  • 2Lu Y,Wang X,\Vang H,et al. Liver TCH78(+ )(;1)3( +)(:l)4(-)01)8(-)T cells contril)ute to inunne hepatitis virus strain 3-in(luc(*d lieji-alic injury tlirough a TNF-a-dfpemlrnt pathway[J].Mol Immunol,2012,52(3-4):229-236.
  • 3Massari S,Ciccarese S,Anlonacci Ral. Slructural and coniparativeanalysis of the T cell receptor gamma (TH(i)locus in Onctolagus fu-niculus [J]. Iinmunogfneticfi,2012,64(10) :773-779.
  • 4Poqqi A,Zaiucolli M ,Bocro S.et al. Differential survival <if 78T cells,apT rells and NK cells upon engagement of NK(;2!) l>y NKG2DI,-expressinglcukemic cells[J].Int J Cancer,2011 , 129(2) :387-396.
  • 5Qiu KM ,Li ZP,Huang J. Research progress of aninuulelta T cell -based irumunotlierapy [J]. Zhejiang Da Xue Bao Yi Xue Ban,2010.39(4):424-429.
  • 6Lu J , Aqqaaral K. Kanji S .et al. Human ovarian lumor cells escape78 T cell recognition partly l>y down refjulating surface expression ofMICA and limiting cell cycle relail milecules [J]. llos One,2011 ,6(9):23348.
  • 7Zhang C,Zhang J , Wei 1.1,et al. Iniltalance of NKG2D and its iu-liihitory counterparts:how (Ws tumor escape i'nini innate immuniiy?[J].Int hniminopharmacol,2005 ,5(7-8) : 1099- 1111.
  • 8Van Belle T[,IJng E, Haase C,et ul. NK(J2D hlockade facilitatesdiabeles prevention by antigen -sptM'ifir Tregs in a vims -iiuiuccdmodel of diabetes [J]. J Autoimmim,2012.31 : 1089-1098.
  • 9李蕾,张万江.抗结核分枝杆菌感染的免疫机制研究[J].医学综述,2008,14(2):266-268. 被引量:6
  • 10臧怡雯,周易明,陈宗祐.NKG2D及其配体在肿瘤免疫中的研究进展[J].复旦学报(医学版),2011,38(4):367-371. 被引量:11

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部